Uncover key drivers, emerging technologies, and competitive movements shaping the drug discovery services market from 2026–2035 with trusted insights from The Business Research Company
How much larger will the Drug Discovery Services Market be in 2030 compared with 2026?
The drug discovery services market has experienced substantial growth in recent years. It is projected to expand from $20.52 billion in 2025 to $23.21 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.1%. Historically, this market expansion has been driven by factors such as pharmaceutical R&D growth, financial constraints on drug developers, the increase in CRO service offerings, the evolution of target-based drug discovery, and strengthened academic-industry partnerships.
The drug discovery services market is projected to experience substantial expansion in the coming years, with its size expected to reach $39.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.4%. This growth during the forecast period can be attributed to elements such as advancements in precision medicine pipelines, the emergence of AI-driven discovery platforms, increased funding for biotech startups, ongoing research into complex diseases, and the need for more efficient lead optimization. Significant trends expected during this forecast period include a rise in the outsourcing of drug discovery activities, the increasing application of AI in target identification, the expansion of early-stage discovery services, a growing demand for biologics drug discovery, and a greater integration of in vitro and in vivo studies.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8324&type=smp
What Drivers Are Guiding Growth Patterns In The Drug Discovery Services Market?
The increasing occurrence of chronic diseases is anticipated to stimulate the expansion of the drug discovery services market moving forward. These conditions are defined as persistent health issues that are typically not curable but can be effectively managed. Drug discovery services are essential for finding and developing new medications to address chronic diseases. As an illustration, in September 2023, data from the World Health Organization, a Switzerland-based intergovernmental public health agency, indicated that chronic noncommunicable diseases caused 41 million deaths annually, constituting 74% of all global deaths. Consequently, the growing prevalence of chronic diseases is expected to support the growth of the drug discovery services market.
Which Segments Are Driving Activity In The Drug Discovery Services Market?
The drug discovery services market covered in this report is segmented –
1) By Type: Chemistry Services, Biology Services
2) By Process: Target Selection, Target Validation, Hit-To-Lead identification, Lead Optimization, Candidate Validation
3) By Drug Type: Biologics Drug , Small Molecule Drug
4) By End user: Pharmaceutical And Biotechnology Companies, Academic Institutes, Other End Users
Subsegments:
1) By Chemistry Services: Medicinal Chemistry, Compound Management, High-Throughput Screening, Lead Optimization
2) By Biology Services: In Vitro Studies, In Vivo Studies, Pharmacokinetics And Pharmacodynamics (PK Or PD), Biomarker Discovery
What Industry Trends Are Transforming The Drug Discovery Services Market?
Leading companies within the drug discovery services market are pioneering advanced technologies like artificial intelligence (AI) and machine learning (ML) to boost the efficiency and accuracy of drug discovery. AI and ML are closely related computer science fields. AI involves developing computer systems that can perform tasks typically requiring human intelligence, while ML, a subset of AI, focuses on using algorithms and statistical models to enable computers to learn from data and make predictions or decisions. A relevant example occurred in February 2024, when Eurofins Discovery, a France-based company offering support services across various sectors, including pharmaceuticals, introduced an innovative platform called DiscoveryAI SAFIRE (Suite of ADMET Predictions for In Silico Refinement and Evaluation). This advanced platform uses proprietary datasets, artificial intelligence (AI), and machine learning (ML) to improve the drug discovery process. SAFIRE is designed to accelerate the discovery of new pharmaceuticals by predicting the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties of molecules. The platform utilizes data from Eurofins Discovery’s extensive BioPrint database, which has been meticulously curated over years of research.
Which Leading Companies Dominate The Drug Discovery Services Market Share?
Major companies operating in the drug discovery services market are Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., Bristol-Myers Squibb Company
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report
How Does The Drug Discovery Services Market Perform Across Major Global Regions?
North America was the largest region in the drug discovery services market in 2025. The regions covered in the drug discovery services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Drug Discovery Services Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8324&type=smp
Browse Through More Reports Similar to the Global Drug Discovery Services Market 2026, By The Business Research Company
Drug Discovery Informatics Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report
Drug Discovery Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report
Drug Discovery Technologies Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model